Publication Cover
Biofouling
The Journal of Bioadhesion and Biofilm Research
Volume 35, 2019 - Issue 2
266
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Antimicrobial activity of nitrochalcone and pentyl caffeate against hospital pathogens results in decreased microbial adhesion and biofilm formation

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 129-142 | Received 03 Jul 2018, Accepted 09 Jan 2019, Published online: 05 Apr 2019

References

  • Aoki N, Muko M, Ohta E, Ohta S. 2008. C-geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity. J Nat Prod. 71:1308–1310. doi:10.1021/np800187f
  • Balachandran C, Duraipandiyan V, Al-Dhabi NA, Balakrishna K, Kalia NP, Rajput VS, Khan IA, Ignacimuthu S. 2012. Antimicrobial and antimycobacterial activities of methyl caffeate isolated from Solanum torvum Swartz. fruit. Indian J Microbiol. 52:676–681. doi:10.1007/s12088-012-0313-8
  • Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A. 2017. Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive Care Med. 43:1464–1475. doi:10.1007/s00134-017-4878-x
  • Benaducci T, Sardi JDCO, Lourencetti NMS, Scorzoni L, Gullo FP, Rossi SA, Derissi JB, de Azevedo Prata MC, Fusco-Almeida AM, Mendes-Giannini MJS. 2016. Virulence of Cryptococcus sp. biofilms in vitro and in vivo using Galleria mellonella as an alternative model. Front Microbiol. 7:290.
  • Birari RB, Gupta S, Mohan CG, Bhutani KK. 2011. Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: experimental and computational studies. Phytomedicine. 18:795–801. doi:10.1016/j.phymed.2011.01.002
  • Boeck P, Bandeira Falcão CA, Leal PC, Yunes RA, Filho VC, Torres-Santos EC, Rossi-Bergmann B. 2006. Synthesis of chalcone analogues with increased antileishmanial activity. Bioorg Med Chem. 14:1538–1545. doi:10.1016/j.bmc.2005.10.005
  • Božić DD, Milenković M, Ivković B, Ćirković I. 2014. Antibacterial activity of three newly-synthesized chalcones & synergism with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus . Indian J Med Res. 140:130–137.
  • Buckari SNA, Jasamai M, Jantan I, Ahmad W. 2013. Review of methods and various catalysts used for chalcone synthesis. MROC. 10:73–83.
  • Budzyńska A, Różalska S, Sadowska B, Różalska B. 2017. Candida albicans/Staphylococcus aureus dual-species biofilm as a target for the combination of essential oils and fluconazole or mupirocin. Mycopathologia. 182:989–995. doi:10.1007/s11046-017-0192-y
  • Chen M, Christensen SB, Blom J, Lemmich E, Nadelmann L, Fich K, Theander TG, Kharazmi A. 1993. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob Agents Chemother. 37:2550–2556. doi:10.1128/AAC.37.12.2550
  • Clinical and Laboratory Standards Institute (CLSI). 2002. Protocol M27-A2. Reference method for broth dilution antifungal susceptibility testing of yeasts. 2nd ed. Pennsylvania: NCCLS, 51p.
  • Clinical and Laboratory Standards Institute (CLSI). 2012. Protocol M27-A9. Reference method for broth dilution antifungal susceptibility testing of bacteria. 2nd ed. Pennsylvania: NCCLS, 70p.
  • Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science. 284:1318–1322. doi:10.1126/science.284.5418.1318
  • de Campos-Buzzi F, Padaratz P, Meira AV, Corrêa R, Nunes RJ, Cechinel-Filho V. 2007. 4'-Acetamidochalcone derivatives as potential antinociceptive agents. Molecules. 12:896–906. doi:10.3390/12040896
  • de Carvalho Dias K, Barbugli PA, de Patto F, Lordello VB, de Aquino Penteado L, Medeiros AI, Vergani CE. 2017. Soluble factors from biofilm of Candida albicans and Staphylococcus aureus promote cell death and inflammatory response. BMC Microbiol. 17:146. doi:10.1186/s12866-017-1031-5
  • Desai V, Desai S, Gaonkar SN, Palyekar U, Joshi SD, Dixit SK. 2017. Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: synthesis, molecular docking and biological evaluation. Bioorg Med Chem Lett. 27:2174–2180. doi:10.1016/j.bmcl.2017.03.059
  • De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, Dimopoulos G, Garnacho-Montero J, Kesecioglu J, Lipman J, et al. 2018. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Med. 44:189–196. doi:10.1007/s00134-017-5036-1
  • Fang Q, Zhao L, Wang Y, Zhang Y, Li Z, Pan Y, Kanchana K, Wang J, Tong C, Li D, Liang G. 2015. A novel chalcone derivative attenuates the diabetes-induced renal injury via inhibition of high glucose-mediated inflammatory response and macrophage infiltration. Toxicol Appl Pharmacol. 282:129–138. doi:10.1016/j.taap.2014.10.021
  • Freires IA, Sardi JC, de Castro RD, Rosalen PL. 2017. Alternative animal and non-animal models for drug discovery and development: bonus or burden? Pharm Res. 34:681–686. doi:10.1007/s11095-016-2069-z
  • Gibson MZ, Nguyen MA, Zingales SK. 2018. Design, synthesis, and evaluation of (2-(pyridinyl)methylene)-1-tetralone chalcones for anticancer and antimicrobial activity. Med Chem. 14:333–343. doi:10.2174/1573406413666171020121244
  • Harriott MM, Noverr MC. 2009. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother. 53:3914–3922. doi:10.1128/AAC.00657-09
  • Hwang G, Marsh G, Gao L, Waugh R, Koo H. 2015. Binding force dynamics of Streptococcus mutans-glucosyltransferase B to Candida albicans. J Dent Res. 94:1310–1317. doi:10.1177/0022034515592859
  • Israf DA, Khaizurin TA, Syahida A, Lajis NH, Khozirah S. 2007. Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells. Mol Immunol. 44:673–679. doi:10.1016/j.molimm.2006.04.025
  • Karkowska-Kuleta J, Bartnicka D, Zawrotniak M, Zielinska G, Kieronska A, Bochenska O, Ciaston I, Koziel J, Potempa J, Baster Z. 2018. The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans. Pathog Dis. 76. doi:10.1093/femspd/fty033
  • Klotz SA, Chasin BS, Powell B, Gaur NK, Lipke PN. 2007. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis. 59:401–406. doi:10.1016/j.diagmicrobio.2007.07.001
  • Kong EF, Tsui C, Kucharíková S, Andes D, Van Dijck P, Jabra-Rizk MA. 2016. Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix. MBio. 7:pii: e01365–p16.
  • Konduru NK, Dey S, Sajid M, Owais M, Ahmed N. 2013. Synthesis and antibacterial and antifungal evaluation of some chalcone based sulfones and bisulfones. Eur J Med Chem. 59:23–30. doi:10.1016/j.ejmech.2012.09.004
  • Lal K, Yadav P, Kumar A, Kumar A, Paul AK. 2018. Design, synthesis, characterization, antimicrobial evaluation and molecular modeling studies of some dehydroacetic acid-chalcone-1,2,3-triazole hybrids. Bioorg Chem. 77:236–244. doi:10.1016/j.bioorg.2018.01.016
  • Lai CH, Rao YK, Fang SH, Sing YT, Tzeng YM. 2010. Identification of 3',4',5'-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells. Bioorg Med Chem Lett. 20:5462–5564. doi:10.1016/j.bmcl.2010.07.094
  • Lazarini JG, Sardi JCO, Franchin M, Nani BD, Freires IA, Infante J, Paschoal JAR, de Alencar SM, Rosalen PL. 2018. Bioprospection of Eugenia brasiliensis, a Brazilian native fruit, as a source of anti-inflammatory and antibiofilm compounds. Biomed Pharmacother. 102:132–139. doi:10.1016/j.biopha.2018.03.034
  • Megaw J, Thompson TP, Lafferty RA, Gilmore BF. 2015. Galleria mellonella as a novel in vivo model for assessment of the toxicity of 1-alkyl-3-methylimidazolium chloride ionic liquids. Chemosphere. 139:197–201. doi:10.1016/j.chemosphere.2015.06.026
  • Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 79:629–661. doi:10.1021/acs.jnatprod.5b01055
  • Ni L, Meng CQ, Sikorski JA. 2004. Recent advances in therapeutic chalcones. Expert Opinion on Therapeutic Patents. 12:1669–1691.
  • Nowakowska Z. 2007. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem. 42:125–137. doi:10.1016/j.ejmech.2006.09.019
  • Ozdemir A, Gokbulut S, Sever B, Ciftci GA, Altıntop MD. 2018. Synthesis and evaluation of a new series of arylidene indanones as potential anticancer agents. Anticancer Agents Med Chem. 18:1394–1404. doi:10.2174/1871520618666171206111923
  • Palanco AC, Lacorte Singulani J, Costa-Orlandi CB, Gullo FP, Strohmayer Lourencetti NM, Gomes PC, Ayusso GM, Dutra LA, Silva Bolzani VD, Regasini LO. 2017. Activity of 3'-hydroxychalcone against Cryptococcus gattii and toxicity, and efficacy in alternative animal models. Future Microbiol. 12:1123–1134. doi:10.2217/fmb-2017-0062
  • Paracatu LC, Bonacorsi C, Farias CMQ, Nazaré AC, Petrônio MS, Regasini LO, Silva DHS, Raddi MSG, Fonseca LM, Ximenes VF. 2014. Alkyl caffeates as anti-Helicobacter pylori and scavenger of oxidants produced by neutrophils. MC. 10:74–80.
  • Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. 2012. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev. 25:193–213. doi:10.1128/CMR.00013-11
  • Pizarro-Cerdá J, Cossart P. 2006. Bacterial adhesion and entry into host cells. Cell. 124:715–727. doi:10.1016/j.cell.2006.02.012
  • Rochelle SLA, Sardi JCO, Freires IA, Galvao LCC, Lazarini JG, Alencar SM, Rosalen PL. 2016. The anti-biofilm potential of commonly discarded agro-industrial residues agains opportunistic pathogens. Ind Crops Prod. 87:150–160. doi:10.1016/j.indcrop.2016.03.044
  • Saito ST, Trentin D. D S, Macedo AJ, Pungartnik C, Gosmann G, Silveira J. D D, Guecheva TN, Henriques JAP, Brendel M. 2012. Bioguided fractionation shows Cassia alata extract to inhibit Staphylococcus epidermidis and Pseudomonas aeruginosa growth and biofilm formation. Evid Based Complement Alternat Med. 2012:1. doi:10.1155/2012/867103
  • Sardi JC, Almeida AM, Mendes Giannini MJ. 2011. New antimicrobial therapies used against fungi present in subgingival sites - a brief review. Arch Oral Biol. 56:951–959. doi:10.1016/j.archoralbio.2011.03.007
  • Sardi JC, Duque C, Mariano FS, Marques MR, Höfling JF, Gonçalves RB. 2012. Adhesion and invasion of Candida albicans from periodontal pockets of patients with chronic periodontitis and diabetes to gingival human fibroblasts. Med Mycol. 50:43–49. doi:10.3109/13693786.2011.586133
  • Sardi JDCO, Pitangui NDS, Rodríguez-Arellanes G, Taylor ML, Fusco-Almeida AM, Mendes-Giannini MJS. 2014. Highlights in pathogenic fungal biofilms. Rev Iberoam Micol. 31:22–29. doi:10.1016/j.riam.2013.09.014
  • Sardi JC, Gullo FP, Freires IA, Pitangui NS, Segalla MP, Fusco-Almeida AM, Rosalen PL, Regasini LO, Mendes-Giannini MJ. 2016. Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp. Diagn Microbiol Infect Dis. 86:387–391. doi:10.1016/j.diagmicrobio.2016.08.002
  • Sardi JCO, Polaquini CR, Freires IA, Galvão LCC, Lazarini JG, Torrezan GS, Regasini LO, Rosalen PL. 2017. Antibacterial activity of diacetylcurcumin against Staphylococcus aureus results in decreased biofilm and cellular adhesion. J Med Microbiol. 66:816–824.
  • Shi J, Yu J, Pohorly JE, Kakuda Y. 2003. Polyphenolics in grape seeds-biochemistry and functionality. J Med Food. 6:291–299. doi:10.1089/109662003772519831
  • Tan Y, Leonhard M, Ma S, Moser D, Schneider-Stickler B. 2017. Dispersal of single and mixed non-albicans Candida species biofilms by β-1,3-glucanase in vitro. Microb Pathog. 113:342–347. doi:10.1016/j.micpath.2017.10.057
  • Tristão TC, Campos-Buzzi F, Corrêa R, Cruz RC, Cechinel Filho V, Bella Cruz A. 2012. Antimicrobial and cytotoxicity potential of acetamido, amino and nitrochalcones. Arzneimittelforschung. 62:590–594.
  • Vaishampayan A, de Jong A, Wight DJ, Kok J, Grohmann E. 2018. A novel antimicrobial coating represses biofilm and virulence-related genes in methicillin-resistant Staphylococcus aureus. Front Microbiol. 9:221. doi:10.3389/fmicb.2018.00221
  • Wang Q, Wang H, Xie M. 2010. Antibacterial mechanism of soybean isoflavone on Staphylococcus aureus. Arch Microbiol. 192:893–898.
  • Xu LC, Siedlecki CA. 2014. Staphylococcus epidermidis adhesion on hydrophobic and hydrophilic textured biomaterial surfaces. Biomed Mater. 9:035003. doi:10.1088/1748-6041/9/3/035003
  • Xu S, Zuo A, Guo Z, Wan C. 2017. Ethyl caffeate ameliorates collagen-induced arthritis by suppressing Th1 immune response. J Immunol Res. 2017:1.
  • Yamamoto T, Yoshimura M, Yamaguchi F, Kouchi T, Tsuji R, Saito M, Obata A, Kikuchi M. 2004. Anti-allergic activity of naringenin chalcone from a tomato skin extract. Biosci Biotechnol Biochem. 68:1706–1711. doi:10.1271/bbb.68.1706
  • Zago CE, Silva S, Sanitá PV, Barbugli PA, Dias CM, Lordello VB, Vergani CE. 2015. Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and-resistant Staphylococcus aureus (MRSA). PLoS One. 10:e0123206. doi:10.1371/journal.pone.0123206
  • Zamani S, Nasiri MJ, Khoshgnab BN, Ashrafi A, Abdollahi A. 2014. Evaluation of antimicrobial resistance pattern of nosocomial and community bacterial pathogens at a teaching hospital in Tehran, Iran. Acta Med Iran. 52:182–186.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.